• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非胃肠胰神经内分泌肿瘤中使用68镓标记的生长抑素类似物的PET及PET/CT检查

PET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors.

作者信息

Sollini Martina, Erba Paola Anna, Fraternali Alessandro, Casali Massimiliano, Di Paolo Maria Liberata, Froio Armando, Frasoldati Andrea, Versari Annibale

机构信息

Nuclear Medicine Unit, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, 42123 Reggio Emilia, Italy.

Regional Center of Nuclear Medicine, University of Pisa, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, 56125 Pisa, Italy.

出版信息

ScientificWorldJournal. 2014 Feb 13;2014:194123. doi: 10.1155/2014/194123. eCollection 2014.

DOI:10.1155/2014/194123
PMID:24693229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3947736/
Abstract

Somatostatin (SST) is a 28-amino-acid cyclic neuropeptide mainly secreted by neurons and endocrine cells. A major interest for SST receptors (SSTR) as target for in vivo diagnostic and therapeutic purposes was born since a series of stable synthetic SST-analouges PET became available, being the native somatostatin non feasible for clinical use due to the very low metabolic stability. The rationale for the employment of SST-analogues to image cancer is both based on the expression of SSTR by tumor and on the high affinity of these compounds for SSTR. The primary indication of SST-analogues imaging is for neuroendocrine tumors (NETs), which usually express a high density of SSTR, so they can be effectively targeted and visualized with radiolabeled SST-analogues in vivo. Particularly, SST-analogues imaging has been widely employed in gastroenteropancreatic (GEP) NETs. Nevertheless, a variety of tumors other than NETs expresses SSTR thus SST-analogues imaging can also be used in these tumors, particularly if treatment with radiolabeled therapeutic SST-analouges PET is being considered. The aim of this paper is to provide a concise overview of the role of positron emission tomography/computed tomography (PET/CT) with (68)Ga-radiolabeled SST-analouges PET in tumors other than GEP-NETs.

摘要

生长抑素(SST)是一种由28个氨基酸组成的环状神经肽,主要由神经元和内分泌细胞分泌。自从一系列稳定的合成生长抑素类似物正电子发射断层显像(PET)出现后,生长抑素受体(SSTR)作为体内诊断和治疗靶点引起了人们的极大兴趣,由于天然生长抑素代谢稳定性极低,不适合临床使用。使用生长抑素类似物对癌症进行成像的基本原理既基于肿瘤对SSTR的表达,也基于这些化合物对SSTR的高亲和力。生长抑素类似物成像的主要适应证是神经内分泌肿瘤(NETs),这类肿瘤通常表达高密度的SSTR,因此在体内可用放射性标记的生长抑素类似物有效地靶向并显影。特别是,生长抑素类似物成像已广泛应用于胃肠胰(GEP)NETs。然而,除NETs外的多种肿瘤也表达SSTR,因此生长抑素类似物成像也可用于这些肿瘤,特别是在考虑使用放射性标记的治疗性生长抑素类似物PET进行治疗时。本文的目的是简要概述用(68)Ga放射性标记的生长抑素类似物PET进行正电子发射断层显像/计算机断层扫描(PET/CT)在GEP-NETs以外的肿瘤中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/d5710d34e4f9/TSWJ2014-194123.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/b255e51c377d/TSWJ2014-194123.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/b0f656148b05/TSWJ2014-194123.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/bcd1cae63e8c/TSWJ2014-194123.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/d5605db8226b/TSWJ2014-194123.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/2bd735af37a8/TSWJ2014-194123.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/9d5c3f751cfc/TSWJ2014-194123.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/4d58a3659d1f/TSWJ2014-194123.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/f8cc3dafb6f6/TSWJ2014-194123.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/f4aece8c40c4/TSWJ2014-194123.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/d5710d34e4f9/TSWJ2014-194123.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/b255e51c377d/TSWJ2014-194123.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/b0f656148b05/TSWJ2014-194123.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/bcd1cae63e8c/TSWJ2014-194123.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/d5605db8226b/TSWJ2014-194123.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/2bd735af37a8/TSWJ2014-194123.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/9d5c3f751cfc/TSWJ2014-194123.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/4d58a3659d1f/TSWJ2014-194123.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/f8cc3dafb6f6/TSWJ2014-194123.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/f4aece8c40c4/TSWJ2014-194123.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/3947736/d5710d34e4f9/TSWJ2014-194123.010.jpg

相似文献

1
PET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors.非胃肠胰神经内分泌肿瘤中使用68镓标记的生长抑素类似物的PET及PET/CT检查
ScientificWorldJournal. 2014 Feb 13;2014:194123. doi: 10.1155/2014/194123. eCollection 2014.
2
Prospective Within-Patient Assessment of the Impact of an Unlabeled Octreotide Pre-dose on the Biodistribution and Tumor Uptake of Ga DOTATOC as Assessed by Dynamic Whole-body PET in Patients with Neuroendocrine Tumors: Implications for Diagnosis and Therapy.前瞻性患者内评估未标记的奥曲肽预给药对神经内分泌肿瘤患者动态全身PET评估的镓[68Ga] DOTATOC生物分布和肿瘤摄取的影响:对诊断和治疗的意义
Mol Imaging Biol. 2021 Oct;23(5):766-774. doi: 10.1007/s11307-021-01600-5. Epub 2021 Apr 7.
3
Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis.镓-68 生长抑素受体 PET 和 PET/CT 对胸和胃肠胰神经内分泌肿瘤患者的诊断性能:一项荟萃分析。
Endocrine. 2012 Aug;42(1):80-7. doi: 10.1007/s12020-012-9631-1. Epub 2012 Feb 20.
4
Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours.关于(68)镓-生长抑素受体正电子发射断层扫描的敏感性以及用于胰腺神经内分泌肿瘤管理的SUVmax参考范围的当前知识。
Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):2072-83. doi: 10.1007/s00259-016-3395-4. Epub 2016 May 13.
5
Application and Dosimetric Requirements for Gallium-68-labeled Somatostatin Analogues in Targeted Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors.镓-68标记的生长抑素类似物在胃肠胰神经内分泌肿瘤靶向放射性核素治疗中的应用及剂量学要求
PET Clin. 2015 Oct;10(4):477-86. doi: 10.1016/j.cpet.2015.06.001. Epub 2015 Jul 8.
6
Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors.(68)Ga-DOTATOC与(68)Ga-DOTATATE在胃肠胰神经内分泌肿瘤PET/CT中的摄取差异
Recent Results Cancer Res. 2013;194:353-71. doi: 10.1007/978-3-642-27994-2_18.
7
Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.胃肠胰神经内分泌肿瘤患者中 68Ga-DOTANOC 与 68Ga-DOTATATE PET/CT 的比较。
J Nucl Med. 2013 Mar;54(3):364-72. doi: 10.2967/jnumed.112.111724. Epub 2013 Jan 7.
8
Somatostatin receptor-based PET/CT of intracranial tumors: a potential area of application for 68 Ga-DOTA peptides?基于生长抑素受体的颅内肿瘤 PET/CT:68Ga-DOTA 肽的潜在应用领域?
AJR Am J Roentgenol. 2013 Dec;201(6):1340-7. doi: 10.2214/AJR.13.10987.
9
F-labeled somatostatin analogs for somatostatin receptors (SSTRs) targeted PET imaging of neuroendocrine tumors (NETs).用于神经内分泌肿瘤(NET)的生长抑素受体(SSTR)靶向正电子发射断层扫描(PET)成像的 F-标记的生长抑素类似物。
Eur J Pharm Sci. 2024 Feb 1;193:106671. doi: 10.1016/j.ejps.2023.106671. Epub 2023 Dec 16.
10
High uptake of (68)Ga-DOTATOC in spleen as compared to splenosis: measurement by PET/CT.
Recent Results Cancer Res. 2013;194:373-8. doi: 10.1007/978-3-642-27994-2_19.

引用本文的文献

1
Squamous cell carcinoma diagnosed as a suspected neuroendocrine tumor by gallium-68 DOTA-Tyr-octreotate positron emission tomography scan: A case report.通过镓-68 DOTA-酪氨酸-奥曲肽正电子发射断层扫描诊断为疑似神经内分泌肿瘤的鳞状细胞癌:一例报告
SAGE Open Med Case Rep. 2025 Sep 7;13:2050313X251372003. doi: 10.1177/2050313X251372003. eCollection 2025.
2
Match Point: Nuclear Medicine Imaging for Recurrent Thyroid Cancer in TENIS Syndrome-Systematic Review and Meta-Analysis.要点:网球综合征中复发性甲状腺癌的核医学成像——系统评价与荟萃分析
J Clin Med. 2024 Sep 10;13(18):5362. doi: 10.3390/jcm13185362.
3
Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines.

本文引用的文献

1
Differentiated thyroid cancer: a new perspective with radiolabeled somatostatin analogues for imaging and treatment of patients.分化型甲状腺癌:放射性标记生长抑素类似物用于患者成像和治疗的新视角。
Thyroid. 2014 Apr;24(4):715-26. doi: 10.1089/thy.2013.0225. Epub 2013 Nov 14.
2
Brief report on the use of radiolabeled somatostatin analogs for the diagnosis and treatment of metastatic small-cell lung cancer patients.放射性标记生长抑素类似物在诊断和治疗转移性小细胞肺癌患者中的应用简要报告。
J Thorac Oncol. 2013 Aug;8(8):1095-101. doi: 10.1097/JTO.0b013e318293f051.
3
68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.
阑尾神经内分泌肿瘤的管理:当前指南见解
Cancers (Basel). 2022 Dec 31;15(1):295. doi: 10.3390/cancers15010295.
4
Imaging of Neuroendocrine Prostatic Carcinoma.神经内分泌前列腺癌的影像学检查
Cancers (Basel). 2021 Nov 17;13(22):5765. doi: 10.3390/cancers13225765.
5
New Directions in Imaging Neuroendocrine Neoplasms.神经内分泌肿瘤影像学的新方向。
Curr Oncol Rep. 2021 Nov 4;23(12):143. doi: 10.1007/s11912-021-01139-2.
6
Safety, tolerability and clinical implementation of 'ready-to-use' gallium-DOTA0-Tyr3-octreotide (Ga-DOTATOC) (SomaKIT TOC) for injection in patients diagnosed with gastroenteropancreatic neuroendocrine tumours (GEP-NETs).用于已确诊胃肠胰神经内分泌肿瘤(GEP-NETs)患者注射的即用型镓 - DOTA0 - Tyr3 - 奥曲肽(Ga - DOTATOC)(SomaKIT TOC)的安全性、耐受性及临床应用
ESMO Open. 2020 Mar;5(2). doi: 10.1136/esmoopen-2019-000650.
7
Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer.用于指导乳腺癌靶向治疗的受体表达核成像的最新进展
Cancers (Basel). 2019 Oct 22;11(10):1614. doi: 10.3390/cancers11101614.
8
The utility of 18F-FDG and 68Ga-DOTA-Peptide PET/CT in the evaluation of primary pulmonary carcinoid: A systematic review and meta-analysis.18F-FDG和68Ga-DOTA-肽PET/CT在原发性肺类癌评估中的应用:一项系统评价和荟萃分析
Medicine (Baltimore). 2019 Mar;98(10):e14769. doi: 10.1097/MD.0000000000014769.
9
Incidental finding of a breast carcinoma on Ga-68-DOTA-1-Nal3-octreotide positron emission tomography/computed tomography performed for the evaluation of a pancreatic neuroendocrine tumor: A case report.在为评估胰腺神经内分泌肿瘤而进行的Ga-68-DOTA-1-Nal3-奥曲肽正电子发射断层扫描/计算机断层扫描中偶然发现乳腺癌:一例报告。
Medicine (Baltimore). 2018 Sep;97(36):e11878. doi: 10.1097/MD.0000000000011878.
10
Evaluation of the Possible Utilization of Ga-DOTATOC in Diagnosis of Adenocarcinoma Breast Cancer.镓-奥曲肽用于乳腺癌诊断的潜在应用评估。
Asia Ocean J Nucl Med Biol. 2018 Winter;6(1):41-49. doi: 10.22038/aojnmb.2017.23695.1168.
68Ga-DOTANOC PET/CT 用于头颈部副神经节瘤患者的基线评估。
J Nucl Med. 2013 Jun;54(6):841-7. doi: 10.2967/jnumed.112.115485. Epub 2013 Mar 21.
4
Measured human dosimetry of 68Ga-DOTATATE.68Ga-DOTATATE 的人体测量剂量学。
J Nucl Med. 2013 Jun;54(6):855-60. doi: 10.2967/jnumed.112.114165. Epub 2013 Mar 20.
5
Comparison of (18)F-FDG PET/CT and (68)Ga-DOTATATE PET/CT imaging in metastasized Merkel cell carcinoma.比较转移性 Merkel 细胞癌的 (18)F-FDG PET/CT 和 (68)Ga-DOTATATE PET/CT 成像。
Clin Nucl Med. 2013 Apr;38(4):283-4. doi: 10.1097/RLU.0b013e318281658e.
6
Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT.用镓-68 DOTATATE PET/CT 提高肿瘤性骨软化症的诊断。
J Clin Endocrinol Metab. 2013 Feb;98(2):687-94. doi: 10.1210/jc.2012-3642. Epub 2013 Jan 7.
7
(68)Ga-DotaTATE PET-CT followed by Peptide Receptor Radiotherapy in combination with capecitabine in two patients with Merkel Cell Carcinoma.两名默克尔细胞癌患者接受(68)镓-多他肽PET-CT检查后,进行肽受体放射性核素治疗并联合卡培他滨治疗。
Int J Clin Exp Med. 2012;5(4):363-6. Epub 2012 Sep 28.
8
Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide.生长抑素受体 PET 在神经内分泌肿瘤中的应用:68Ga-DOTA0,Tyr3-奥曲肽与 68Ga-DOTA0-兰瑞肽的比较。
Eur J Nucl Med Mol Imaging. 2013 Feb;40(3):364-72. doi: 10.1007/s00259-012-2286-6. Epub 2012 Nov 14.
9
Comparison between F-18 fluorodeoxyglucose and Ga-68 DOTATOC in metastasized melanoma.F-18氟脱氧葡萄糖与Ga-68 DOTATOC在转移性黑色素瘤中的比较。
Nucl Med Commun. 2013 Jan;34(1):47-9. doi: 10.1097/MNM.0b013e32835ae4ed.
10
68Ga-DOTATATE-PET/CT positive metastatic lymph node in a 69-year-old woman with Merkel cell carcinoma.68Ga-DOTATATE-PET/CT 阳性转移性淋巴结于一位 69 岁 Merkel 细胞癌女性患者。
Clin Nucl Med. 2012 Nov;37(11):1108-11. doi: 10.1097/RLU.0b013e318266d3b3.